ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
China's largest provider of pharmaceutical chemistry research services, WuXi PharmaTech, has started operating labs in Tianjin, in China's northeast. The Shanghai-based firm says it has relocated a first group of scientists to the 130,000-sq-ft site, in the Tianjin Economic Development Zone. Although Shanghai will remain WuXi's main base of operations, it earlier told C&EN that the new facility was prompted by surging salaries in Shanghai (C&EN, Aug. 21, 2006, page 15).
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X